Chevron Corp. (0R2Q)
London Exchange · UK · prices in USD · close of 22 Oct 2026
Key indicators
| Last close | USD 226.26 |
|---|---|
| 52-week range | 87.14 – 230.33 |
| Return, 1 month / 3 months | +11.4% / +18.4% |
| Return, 1 year / 3 years | +52.5% / +53.6% |
| Trend | Uptrend |
| RSI (14) | 73 |
| Volatility (1 year) | 108.6% |
| Worst drawdown (1 year) | -58.5% |
| Average daily value traded | 2.11M USD |
| Dividend yield | 3.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Chevron is an energy company based in the United States that explores for and produces crude oil and natural gas, refines and markets fuels, and makes petrochemicals and lubricant additives. Its customers include motorists, airlines, shipping firms, industrial businesses and chemical manufacturers, served through fuel stations, pipelines, terminals and supply agreements. The company also operates in power generation and lower-carbon energy ventures, drawing on its long experience in large-scale engineering and project management across many countries.
On this site Chevron Corp. appears as a stock on the London Exchange (UK), code 0R2Q, with prices in US dollars (USD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Chevron Corp. (0R2Q) trades on the London Exchange in UK. It last closed at USD 226.26 on 22 October 2026.
Its price-based Market X-Ray is 61 out of 100 (a fair price profile), ranking 1,204 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 52.5% and over the last three months it rose 18.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 89 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 20.1% | ||
| From 52-week high | -0.1% | ||
| Momentum | 84 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 18.4% | ||
| 6-month return | 23.1% | ||
| 12-month return, skipping the last month | 36.9% | ||
| Stability (higher is calmer) | 9 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 108.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -58.5% | ||
| Liquidity | 61 · Fair | Moderate trading activity. | |
| Average daily value traded | 2.11M USD | ||
| Zero-volume days | 1.7% | ||
| Income | 69 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 3.1% | ||
| Years with dividends | 6 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +3.0% |
|---|---|
| 1 month | +11.4% |
| 3 months | +18.4% |
| 6 months | +23.1% |
| 1 year | +52.5% |
| 3 years | +53.6% |
| 5 years | +145.8% |
Signals
| 50-day / 200-day average | 210.14 / 188.47 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | Yes |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 5.45 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 18 Aug 2026 | USD 1.7800 |
| 18 May 2026 | USD 1.7800 |
| 16 Feb 2026 | USD 1.7800 |
| 17 Nov 2025 | USD 1.7100 |
| 18 Aug 2025 | USD 1.7100 |
| 16 May 2025 | USD 1.7100 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.